USPTO 2015–2025 USPTO PatentsView US Corporation

Medi Manufacturing, Inc.

USPTO PatentsView assignee record - 14 granted patents across 6 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Medi ranks #20,064 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 6 technology areas.

#20,064
of 49,997 US assignees by volume
Top 20%
by Innovation Score (47.0/100)
14.9
avg claims per patent
+60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20064 · US Corporation #20,064 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,064/49,997
  • PHOTO-FINISH Marsupial Holdings
  • CPC-NARROW A61F · 6 areas
  • INNOV-PAR 47.0/100
  • CLAIMS-RICH 14.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +60% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Marsupial Holdings, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medi’s 47.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Medi

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Medi's Innovation Score is 47.0/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Medi?

Each dot is one of Medi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medi’s own 14.9 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Medi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 510152025 Granted patents (volume) Avg claims / patent Marsupial Holdings, Inc. - 14, 18Marsupial HoldingsMashgin Inc. - 14, 21MashginMasterspas, LLC - 14, 11.07MasterspasMathers Hydraulics Technologies Pty Ltd - 14, 17.93Mathers Hydraulic…Medi&Gene Inc. - 14, 19.5Medi&GeneMedical & Biological Laboratories Co., Ltd. - 14, 9.79Medical & Biologi…Medipixel, Inc. - 14, 15.64MedipixelMeinan Machinery Works, Inc. - 14, 11.86Meinan Machinery…Medi Manufacturing, Inc. - 14, 14.93Medi Manufacturing
Medi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medi's grants concentrate

Medi Manufacturing, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (3 grants) versus a trough of 2 in 2018. By volume, Medi sits between Marsupial Holdings, Inc. and Meinan Machinery Works, Inc..

Medi's three-year grant acceleration

Medi Manufacturing, Inc. shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Medi's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medi holds 14 patents at rank #20,083, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medi

By rank, the assignees closest to #20,083 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Medi's primary technology class.

Medi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2017201820212022202320242025 1
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Medi Manufacturing, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 3 21.4%
2018 2 14.3%
2021 2 14.3%
2022 2 14.3%
2023 2 14.3%
2024 2 14.3%
2025partial year 1 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Medi Manufacturing, Inc.'s patent record in context - here's where to go next.

  • Medi Manufacturing, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #20,064 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Medi Manufacturing, Inc. against Marsupial Holdings, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.